Dbv technologies announces results of its 2023 ordinary and extraordinary general meeting

Montrouge, france, april 12, 2023 dbv technologies announces results of its 202 3 ordinary and extraordinary general meeting shareholders a pprove d a ll p roposed r esolutions dbv technologies (euronext: dbv – isin: fr0010417345 – nasdaq stock market: dbvt), a clinical-stage biopharmaceutical company, today held its ordinary and extraordinary general meeting. the general meeting was chaired by michel de rosen, chairman of dbv technologies.
DBVT Ratings Summary
DBVT Quant Ranking